NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study

Recruiting now

Conditions studied: Intracranial Aneurysm

In brief

The purpose of the Pipeline™ Vantage Embolization Device with Shield Technology™ Post Approval Study (PAS) ("Pipeline™ Vantage PAS") is to collect safety and effectiveness data in patients undergoing treatment for intracranial aneurysms (IA) using the Pipeline™ Vantage Embolization Device with Shield Technology™ ("Pipeline™ Vantage Device") in a post approval setting.

Key facts

Study ID
NCT06604884
Run by
Medtronic Neurovascular Clinical Affairs
People needed
118
Starts
2025-12-12
Expected to finish
2033-09-01
Last updated by the study team
2026-06-23

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.